Skip to main content
SpringerLink
Log in

Erektile Dysfunktion

Erectile dysfunction

  • Themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Summary

Erectile Dysfunction is one of the most prevalent sexual disorders in men. According to the current literature the prevalence is about 16% for all men. The diagnostic workup of a patient suffering from E.D. is a detailed anamnesis, a physical and endocrinological evaluation and the suggestion of the optimal therapeutic treatment. The therapeutic application of PDE-5 inhibitors has made the therapy of E.D. much easier. It is a safe and highly efficient therapeutic option. But man must not forget that in severe cases of erectile dysfunction, the application of SKAT therapy, penile implants or vacuum devices might be necessary. Since a functioning sex life is important not only for the men, but also for the couple, a more open attitude of us, physicians, is desirable to help more men who suffer from this sexual dysfunction.

Zusammenfassung

Die erektile Dysfunktion ist eine der häufigsten Sexualstörungen bei Männern. Die Prävalenz beträgt lt. aktueller Literatur ca. 16 % . Die diagnostische Abklärung eines E. D.-Patienten umfasst eine detaillierte Anamnese, eine physikalische Untersuchung und eine endokrinologische Basisevaluation. Die therapeutische Verabreichung von PDE-5-Inhibitoren hat die Therapie der E. D. um vieles einfacher gemacht, da es sich um eine sichere und hoch effiziente orale Therapieoption handelt. Aber man darf nicht vergessen, dass in schweren Fällen fiese Therapie teilweise nicht ausreichend hilft und die Verabreichung der SKAT-Therapie und die Implantation von Penisprothesen oder die Verwendung von Vakuumpumpen notwendig sein kann. Da ein funktionierendes Sexualleben nicht nur für den betroffenen Mann allein, sondern immer auch für das Paar wichtig ist, wäre ein offener Zugang zu diesem Thema durch uns Ärzte wünschenswert, um mehr Männern mit dieser Sexualstörung helfen zu können.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  • NIH. NIH consensus conference: impotence. NIH Consensus development Panel on impotence. JAMA, 270: 83–90, 1993

    Article  Google Scholar 

  • Feldmann HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol, 151: 54–61, 1994

    Google Scholar 

  • Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction. Results of the "Cologne Male Survey". Int J Impot Res, 12: 305–311, 2000

    Article  CAS  PubMed  Google Scholar 

  • Rosen RC, Fisher WA, Eardly I, et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Opin, 20: 607–617, 2004

    Article  Google Scholar 

  • Ponholzer A, Tremmel C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol, 47: 80–85, discussion 85–86, 2005

    Article  PubMed  Google Scholar 

  • Selvin E, Burnett AL, Platz EA, et al. Prevalence and risk factors for erectile dysfunction in the USA. Am J Med, 120: 151–157, 2007

    Article  PubMed  Google Scholar 

  • Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol, 44: 360–365, 2003

    Article  PubMed  Google Scholar 

  • Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA, 293: 2648–2653, 2005

    Article  CAS  PubMed  Google Scholar 

  • Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders. A guide to assessment and treatment in family practice. J Fam Pract, 44: 33–43, 1997

    CAS  PubMed  Google Scholar 

  • Jackson G, Rosen RC, Kloner RA, et al. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med, 3: 28–36, 2006

    Article  CAS  PubMed  Google Scholar 

  • Ponholzer A, Tremmel C, Obermayr R, et al. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol, 48: 512–518, 2005

    Article  PubMed  Google Scholar 

  • Rosen RC, Leary M, Altwein J, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 49: 822–830, 1997

    Article  CAS  PubMed  Google Scholar 

  • Heidler S, Temml C, Broessner C, et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol, 177: 651–654, 2007

    Article  PubMed  Google Scholar 

  • Burchardt M, Burchardt T, Anastasiadis AG, et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res, 13: 276–281, 2001

    Article  CAS  PubMed  Google Scholar 

  • Davis-Joseph B, Tiefer L, Melmann A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology, 45: 498–502, 1995

    Article  CAS  PubMed  Google Scholar 

  • Esposito K, Guigliano F, Di Palo, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomised controlled trial. JAMA, 291: 2978–2984, 2004

    Article  CAS  PubMed  Google Scholar 

  • Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology, 56: 302–306, 2000

    Article  CAS  PubMed  Google Scholar 

  • Wespes E, Wildschutz T, Roumeguere T, et al. The place of surgery for vascular impotence in the third millenium. J Urol, 170: 1284–1286, 2003

    Article  PubMed  Google Scholar 

  • Rosen RC. Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am, 28: 269–278, 2001

    Article  CAS  PubMed  Google Scholar 

  • Fava M, et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction. J Clin Psychiatry, 67: 240–246, 2006

    Article  CAS  PubMed  Google Scholar 

  • Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil study group. N Engl J Med, 338: 1397–1404, 1998

    Article  CAS  PubMed  Google Scholar 

  • Taylor J, Baldo OB, Storey A, et al. Differences in side-effect duration and related bother levels between phosphodiesterase type5 inhibitors. BJU, 103: 1392–1395, 2009

    Article  CAS  Google Scholar 

  • Porst H, Rosen R, Padma-Nathan H, et al, and the Vardenafil Study Group. The efficacy and tolerability of vardenafil, a new oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res, 13: 192–199, 2001

    Article  CAS  PubMed  Google Scholar 

  • Porst H, Huebler D, Padma Nathan H, et al. Tadalafil allows men with erectile dysfunction to have sexual intercourse up to 36 hours postdose. Int J Imp Res, 14(S4): S60, 2002

    Google Scholar 

  • Porst H, Guiliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol, 50: 351–359, 2006

    Article  CAS  PubMed  Google Scholar 

  • Kloner RA. Novel type 5 phosphodiesterase inhibitors: assessing hemodynamic effects and safety parameters. Clin Cardiol, 27: 120–125, 2004

    Article  Google Scholar 

  • Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med, 334: 873–877, 1996

    Article  CAS  PubMed  Google Scholar 

  • Derouet H, Caspari D, Rhode V, et al. Treatment of erectile dysfunction with external vacuum devices. Andrologia, 31(S1): 89–94, 1999

    Article  PubMed  Google Scholar 

  • Montorsi F, Rigatti P, Carmignani G, et al. AMS three-piece inflatable implants for erectile dysfunction: a longterm multi-institutional study in 200 consecutive patients. Eur Urol, 37: 50–55, 2000

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Urologie und Andrologie, Paracelsus Medizinische Privatuniversität Salzburg, Salzburg, Austria

    Brigitte Esterbauer

  2. Fachbereich für Urologie, spezielle urologische Chirurgie und Andrologie, Emco Privatklinik, Bad Dürrnberg, Salzburg, Austria

    Andreas Jungwirth

Authors
  1. Brigitte Esterbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Jungwirth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brigitte Esterbauer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esterbauer, B., Jungwirth, A. Erektile Dysfunktion. Wien Med Wochenschr 159, 529–534 (2009). https://doi.org/10.1007/s10354-009-0719-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-009-0719-z

Keywords

Schlüsselwörter

Search

Navigation